clinical trial · NCT00648791
Fasting Study of Finasteride Tablets 5 mg and Proscar Tablets 5 mg
HealthyFinasteride Tablets 5 mgProscar Tablets 5 mg
brief summary
The objective of this study was to investigate the bioequivalence of Mylan's finasteride 5 mg tablets to Merck's Proscar® 5 mg tablets following a single, oral 5 mg (1 x 5 mg) dose administration under fasting conditions.
started
Sep 1, 2004
primary completion
Oct 1, 2004
completion
Oct 1, 2004
last updated
Apr 24, 2024
official title
Single-Dose Fasting In Vivo Bioequivalence Study of Finasteride Tablets (5 mg; Mylan) and Proscar Tablets (5 mg; Merck) in Healthy Male Volunteers
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol